Stock markets tread water as investors eye US-China talks

Published 05-APR-2019 10:39 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Global stock markets moved mostly sideways on Thursday as hopes that China and the United States would reach a breakthrough in trade talks was counteracted as nervous investors took profits.

Investors in British assets were cautious as they weighed the chances that Britain would crash out of the EU without a deal next week, with both the pound and the London stock market posting losses.

High-level talks between China and the United States continued in Washington, although the White House signaled late in the afternoon the two sides were still a way from a done deal following this round of talks, which continue Friday.

President Donald Trump, who met with Beijing's trade envoy Liu He, said that the talks were "looking very good" but that the two sides needed more time.

"We will probably know over the next four weeks. It may take two weeks after that," Trump told reporters.

Yet, nine months into the two countries' trade war, the announcement was anticlimactic, as the White House had earlier stoked anticipation that Trump could announce a date for a summit to clinch a final deal with his Chinese counterpart.

The Dow and S&P 500 both notched modest gains, while the Nasdaq edged lower.

Earlier, London and Paris both dipped, while Frankfurt advanced, shrugging off weak German industrial orders data.

In London, the government redoubled its efforts on Thursday to win over the main opposition party in a last-gasp bid to avoid a chaotic exit from the European Union next week.

The latest round of cross-party talks came after lawmakers tried to safeguard against a doomsday ending to the 46-year membership in Europe by fast-tracking a bill Wednesday night seeking to delay Brexit.

The premier has already said she will seek a second "short" delay at an EU summit on April 10.

Parliament remains divided with hardliners fearing a "soft" divorce will leave Britain still linked to the bloc.

The pound slid against both the dollar and the euro "as markets considered the prospect of the Brexit fog thickening and lasting longer," said Joe Manimbo, senior market analyst at Western Union Business Solutions.

- Key figures around 2100 GMT -

New York - Dow: UP 0.6 percent at 26,384.63 (close)

New York - S&P 500: UP 0.2 percent at 2,879.39 (close)

New York - Nasdaq: DOWN 0.1 percent at 7,891.78 (close)

London - FTSE 100: DOWN 0.2 percent at 7,401.94 (close)

Frankfurt - DAX 30: UP 0.3 percent at 11,988.01 (close)

Paris - CAC 40: DOWN 0.1 percent at 5,463.80 (close)

EURO STOXX 50: UP 0.2 percent at 3,441.93 (close)

Tokyo - Nikkei 225: UP 0.1 percent at 21,724.95 (close)

Hong Kong - Hang Seng: DOWN 0.2 percent at 29,936.32 (close)

Shanghai - Composite: UP 0.9 percent at 3,246.57 (close)

Pound/dollar: DOWN at $1.3077 from $1.3158 at 2100 GMT on Wednesday

Euro/pound: UP at 85.82 pence from 85.35 pence

Euro/dollar: DOWN at $1.1221 from $1.1233

Dollar/yen: UP at 111.66 yen from 111.49 yen

Oil - Brent Crude: UP 9 cents at $69.40 per barrel

Oil - West Texas Intermediate: DOWN 36 cents at $62.10

© Agence France-Presse



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X